Skip to main content
. 2016 Apr 15;41(3):247–256. doi: 10.1016/j.jgr.2016.04.003

Fig. 1.

Fig. 1

Effects of KG-135 on the proliferation and cell cycle distribution of A549 human nonsmall cell lung cancer cells. (A) After treatment with KG-135 for 72 h, the cell viability of A549 cells was measured using sulforhodamine B binding assay. (B) The cell cycle distribution was analyzed using flow cytometry. Cell viability data are expressed as mean ± standard error and analyzed as described in Section 2.